Jim Cramer Dissects Kimberly-Clark’s Acquisition of Kenvue

“Alright, this is 1 we’ve talked astir a bunch, Kimberly-Clark’s bold, astir $49 cardinal bid to bargain Kenvue, which is the J&J’s aged over-the-counter concern that makes Tylenol, Band-Aids, Aveeno, and truthful galore different household names. I deliberation it’s incredibly compelling arsenic Kenvue banal has… adjacent chopped successful fractional from wherever it came public. Of course, determination are risks. The Secretary of Health and Human Services has blamed Tylenol for causing autism. But helium seems to deliberation benignant of everything causes autism.

Pixabay/Public Domain

Kimberly-Clark Corporation (NASDAQ:KMB) manufactures idiosyncratic attraction products and provides items specified arsenic diapers, wipes, feminine and incontinence attraction products, and household insubstantial goods. Its brands see Huggies, Kotex, Depend, Kleenex, Scott, and Cottonelle.

While we admit the imaginable of KMB arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the champion short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.